Clinical Trial Update: Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies [Phase 3]

View source ↗

Summary

Follow-up Phase 3 study assessing long-term safety and outcomes in infants and children born to mothers treated in retosiban studies; completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstetric Labour
• Premature Birth

Drugs mentioned

• Retosiban (retosiban)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Obstetric Labour, Premature | Phase 3 | Status: COMPLETED | Results posted: 2020-07-09